(Cys(Acm)33)-Endostatin (6-49) (human) is a truncated form of endostatin with a cysteine substitution at position 33 that enhances stability and facilitates structural studies. The Acm protection group at cysteine ensures controlled disulfide bond formation. Researchers use this peptide to explore its anti-angiogenic properties and its role in tumor suppression, particularly in cancer treatment models.
CAT No: A4802
Synonyms/Alias:(Cys(Acm)1343)-Collagen XVIII α1 Chain (1316-1359) (human)
2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
3. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More